Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Atopic Dermatitis
Interventions
DEVICE

LimpiAD 2,5% plus cream

A topical formulation that contains Hyaluronic Acid conjugated with a bacterial wall fragment of Cutibacterium species (HAc-40) and an emollient base. LimpiAD exerts its post-biotic action through the seizure/ trapping and inactivation of catabolites and / or toxins produced by S. aureus as well as protecting the hydrolipidic film, especially in case of dryness, itching, and, in conditions of altered microbiome

OTHER

Vehicle

"Vehicle of LimpiAD 2.5 % plus cream which has the qualities of an emollient technically enriched with active ingredients known for their use in AD (plus emollient) - having the same ingredients of LimpiAD 2.5% Plus but without the HAc-40 component."

OTHER

Emollient

Standard emollient used as neutral control, having only a moisturizing and skin barrier action, which represents the basic standard treatment (basic therapy) of atopic dermatitis according to the European Guidelines.

Trial Locations (5)

80035

RECRUITING

Dr. Carlomagno Francesco, Nola

80038

NOT_YET_RECRUITING

Dr. D'Onofrio Antonietta, Pomigliano d'Arco

80053

RECRUITING

Dr. Chianese Pierluigi, Castellammare di Stabia

84090

RECRUITING

Dr. Occhinegro Aurelio, Salerno

84091

RECRUITING

Dr. Giuseppe Ruggiero, Battipaglia

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Advice Pharma Group srl

INDUSTRY

lead

Aileens Pharma SRL

INDUSTRY

NCT05984420 - Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis | Biotech Hunter | Biotech Hunter